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Introduction
Precision Medicine and Digital Health are increasingly 
important areas that are reliant on “convergent” or 
“cross-industry” innovation (Sabatier et al. 2012; Thak-
ur et al., 2012). A consequence of convergence is that it 
brings more uncertainty and allows greater influence 
from new knowledge and actors, including previously 
disparate technologies and capabilities (Rikkiev & Mäk-
inen, 2013). In turn, there is an added complexity be-
cause convergence contradicts the two dominant forms 
of organizational learning, namely simplification and 
specialization (Levinthal & March, 1993). This research 
focuses on the uncertainty and complex integration is-
sues that arise from the emerging ecosystem, from de-
veloping the innovation and in forming a viable value 
network. 
Much of the extant innovation literature has focused on 
innovation by incumbents in existing industries or with 
existing value-chain partners (Enkel & Gassmann, 
2010). More recently, there has been increasing interest 
in “cross-industry” or “convergent” innovation (Gass-
mann et al. 2010; Stieglitz, 2003). However, conver-
gence can result in higher levels of equivocality, 
uncertainty, and risk as the diverse technology, alliance 
partners, and ecosystems merge (Enkel & Heil, 2014; 
Hacklin, 2005; Mason et al., 2013). These considera-
tions manifest themselves as different integration chal-
lenges that depend on the nature of the convergence 
(Rikkiev & Mäkinen, 2013). 
For convergence in healthcare technologies, apart from 
several practitioner articles (Eselius et al., 2008; Gupta 
et al., 2013; Mason et al., 2013), there are limited studies 
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“ ”Between the idea
And the reality
Between the motion 
And the act
Falls the Shadow
T. S. Eliot (1888–1965)
Poet, dramatist, and literary critic
In The Hollow Men (1925)
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that examine the implications for technological or busi-
ness model discontinuities (Bojovic et al., 2015; Sabati-
er et al., 2012) and these few (Bernabo et al., 2009; Dubé 
et al., 2014; Ramachandran et al., 2011; Shmulewitz et 
al., 2006) focus more on the phenomenon than on the 
implications. 
Using empirical analyses in five longitudinal case stud-
ies with a combination of interviews, field observations 
(e.g., meetings and workshops), and documents, our ex-
ploratory research findings point to a need to embrace 
the complexity. We propose the adoption of ap-
proaches that balance taking “credibility-seeking” and 
“advantage-seeking” positions using non-ergodic 
routines that navigate, negotiate, and nurture with a 
combination of “analysis” and “synthesis” actions to 
manage integration. 
Theoretical Background 
Addressing uncertainty and complexity
Uncertainty and risk are inherent in innovation and 
arise from four types of complexity: evolutionary, tem-
poral, relational, and cultural (Garud et al., 2013). Im-
portantly, there are inherent differences between 
managing risks (with known probabilities) and uncer-
tainty (or “unknown unknowns”) (Teece et al., 2016). 
The major uncertainties and risks in innovation are gen-
erally considered to be technological, regulatory, and 
market based (Hobday, 1998), and they are typically ad-
dressed by a variety of mechanisms to “manage com-
plexity”, resulting in simplification and specialization 
(Levinthal & March, 1993). However, such approaches 
create limitations and may inhibit the innovation itself 
(Garud et al., 2013). Although several of these chal-
lenges are acknowledged (Rikkiev & Mäkinen, 2013), 
there has been limited empirical research to under-
stand how they are addressed. 
Differences between the nature of innovation and its 
impact have been considered in both the innovation lit-
erature (Abernathy & Clark, 1985) and the diffusion lit-
erature (Rogers, 2003). In extant literature, there is 
more focus on the management of risk (Evanschitzky et 
al., 2012) than on addressing uncertainty, which is con-
sidered more likely and harder to manage (Teece et al., 
2016). 
In addressing uncertainty, McGrath (2001) confirms the 
earlier findings of March (1991) that the degree of ex-
ploration is important; broader searches across more 
variety can improve performance. The dynamic capab-
ility literature points to the use of sensing, seizing, and 
transforming to better manage uncertainty (Teece et 
al., 2016), with abduction (as a mode of inference) be-
ing important to create new thinking for subsequent 
testing. This suggests creative abduction (Schurz, 2008) 
is more relevant (versus selective abduction, which 
chooses from multiple explanations), although creat-
ive abduction is rarely discussed in the literature (Pren-
dinger & Ishizuka, 2005). 
Sommer and colleagues (2009) identify two ap-
proaches to respond to uncertainty: selectionism and 
trial-and-error. Selectionism refers to attempting 
many solutions in parallel and selecting the best based 
on the outcomes. However, such an approach can be 
costly and potentially inefficient. Trial-and-error learn-
ing refers to adjusting activities and targets as new in-
formation becomes available. The combination of 
complexity and uncertainty, and the need for creative 
and exploratory approaches using limited and often 
equivocal information, is counter to much of the tradi-
tional innovation literature with linear processes and 
defined decision criteria, as highlighted by Garud and 
colleagues (2013) and Bessant and colleagues (2005).
Integration challenges
Integration, by (re)combining knowledge, is inherent 
in innovation (Grant, 1996; Kogut & Zander, 1993; 
Teece, 1996). As well as knowledge or technology integ-
ration, there is a need for market and organization in-
tegration (Tidd & Bessant, 2013). Much of the 
“integration” literature focuses on intra-organization 
and cross-functional integration as Evanschitzky and 
colleagues (2012) identified in their meta-analysis of 
success factors in 233 innovation studies. Although in-
tegration (internal and external) has been identified as 
an indicator of innovation performance, it is moder-
ated by equivocality (Koufteros et al. 2005). Yet, equi-
vocality is itself inherent in convergence. 
Alliance formation (Colombo et al., 2006; Eisenhardt & 
Schoonhoven, 1996) and management under condi-
tions of high uncertainty would, therefore, appear to 
be a critical capability for startups and new ventures 
within an incumbent firm. Previous literature has iden-
tified the need for a highly integrated value network as 
a key factor in performance (Prajogo & Olhager, 2012), 
but this presupposes a strong understanding of the 
needs and capabilities of the alliance partners. In con-
vergent innovation, ecosystems and value networks 
are emerging, so a comprehensive understanding may 
be lacking. 
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Systems-integration risks are not new (for example, see 
Henderson & Clark, 1990), but have traditionally been 
addressed by concepts such as modularity (Baldwin & 
Clark, 1997; Schilling, 2000). However, the presumption 
in such an approach is that the knowledge is well codi-
fied (Cardinal et al., 2001). In convergence, this is more 
challenging, because such codification is initially lim-
ited.
What is less clear in the extant literature is how this 
complexity and integration is addressed. Garud and col-
leagues (2013) identified some challenges and resulting 
gaps in both research and practice, and they call for ap-
proaches that embrace the complexity as a “generative” 
process, rather than trying to simplify and “manage” it.
Research Design
This research aims to address these issues by consider-
ing the question of how organizations address the chal-
lenges of integration in convergent technology 
innovation within the wider context of convergent in-
novation for healthcare and medical technologies in 
emerging ecosystems.
Given the context of the enquiry, and the evolving 
nature of the setting, a qualitative approach was adop-
ted (Yin, 2014). The design consisted of two main 
phases (see Figure 1). An exploratory phase involved 27 
semi-structured interviews from a wide range of ecosys-
tem stakeholders, which enabled better understanding 
of the emerging ecosystem itself (Table 1). The inter-
views were analyzed inductively using the Gioia (2012) 
method to identify “dimensions”. From these dimen-
sions and a review of innovation and ecosystem literat-
ure, an investigational tool was developed (using 
abduction) for use in the second phase. The second 
Convergent Innovation in Emerging Healthcare Technology Ecosystems
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Table 1. Ecosystem interviews to develop context and 
constraints
Figure 1. Overall research approach
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phase was based on empirical analyses of five in-depth 
longitudinal case studies conducted over 15- to 24-
month periods employing a combination of interviews, 
field observations, and primary documents (obtained 
under confidentiality) as data sources, together with 
supplementary evidence from public documents. The 
cases involved three established companies and two 
startups, with 62 case study interviews, 41 observations, 
and over 100 documents (see Table 2). Further ecosys-
tem interviews were also conducted to provide contem-
poraneous context. The data were collected and 
analyzed using thematic and process coding to identify 
patterns. A further in-depth analysis based on Sayer’s 
(1992) approach was then used to identify the potential 
underlying causal mechanisms using the ecosystem 
data as context (conditions and constraints).
Findings
The exploratory ecosystem interviews identified major 
issues for actors in understanding the ecosystem itself, 
the diverse perspectives of actors, and how to create 
and capture value. But the ecosystem not only creates 
“problems”, it also provides “solutions” for innovators. 
There is therefore an explicit link between the ecosys-
tem, the innovation, and capabilities needed. 
All the cases provided evidence that organizations un-
dertook activities to search and sense-make (and sense-
give) in the emerging ecosystem. But the nature of those 
search and sense-making activities differed; those ad-
opting a more exploratory and engaging approach, for 
example by snowballing (Goodman, 1961) to identify 
Table 2. Case research sources
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distant actors and then engaging them, appear to be 
more successful. The case findings point to extensive, 
repeated, and direct interactions as important for 
sense-making. Decision-making processes were largely 
informal (and invariably supported by external expert-
ise), using directional criteria, and focused on key is-
sues in terms of balancing value and risk. 
Given the newness of the ecosystem, firms invested in 
activities that aided understanding and created credibil-
ity among potential partners, enabling them to engage, 
negotiate, and move to a position of advantage-seeking. 
However, these efforts were balanced by activities that 
continued to support or sustain the ecosystem itself, of-
ten with no immediate return, as described by the lead-
er of one case (DH1): “…there needs to be ‘congruence’, 
a real alignment. Not just in terms of the outcome, but 
also cultural and how you are going to do it. Connec-
tions do not just happen – you need to ‘cultivate’ to cre-
ate the right opportunities.”
The uncertainty in the ecosystem presents issues, but is 
also a potential source of solutions. The casual mechan-
ism analysis, derived from Sayer (1992), suggests organ-
izations need to “navigate” the ecosystem, “negotiate” 
a position, and “nurture” the innovation by a combina-
tion of “credibility-seeking” and “advantage-seeking” 
activities that are “generative” in that they create oppor-
tunities. These activities appear to be underpinned by 
five interrelated processes or organizational routines: 
searching, sense-making, selecting, shaping, and sus-
taining. A series of findings and insights from our case 
studies are summarized in Table 3. These activities and 
routines support four main objectives to shape the in-
novation and create value, to manage risks and the in-
tegration, and to develop the value network and wider 
ecosystem (Figure 2).
Discussion and Implications for Practice
The integration problem, as identified earlier, is com-
plex and does not just include technological or market 
risk, but requires a simultaneous balancing of risk 
around four aspects: i) technical systems integration, ii) 
commercial or business models, iii) value network, and 
iv) organizational integration (O’Connor & Rice, 2013).
Technical systems and integration risks
The bringing together of different scientific, technical, 
and industry knowledge inevitably adds a new dimen-
sion to the technical risk – that of technical systems in-
tegration. The cases highlighted several examples: Case 
NMD sought to integrate diverse science and techno-
logy from biology, micro-electronics, flexible electron-
ics, new neural interfaces, energy harvesting (all at a 
much smaller scale than previously conceived), and 
new control algorithms. Similarly, Case MLD integrated 
visual cognition science with “millisecond scale” re-
sponse monitoring on mobile technologies, cloud com-
puting, and artificial intelligence (AI) technology. 
Figure 2. Proposed activity system model of convergent innovation
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Table 3. Example case findings and insights
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To overcome these challenges, all the cases worked in a 
collaborative way with other knowledge and alliance 
partners, creating opportunities to understand and 
share. This finding suggests that the approach appears 
more dependent on building relationships, rather than 
on information codification (Tidd & Bessant, 2013) and 
traditional technology integration approaches. 
Market and business model risk
Convergent innovation, with increasingly digital con-
tent, provides opportunities for innovators to disrupt 
existing health and care pathways, making the identific-
ation of the value proposition and customer more com-
plex and riskier. The nature of the technology used by 
Case MLD provided multiple options for business mod-
els, providing a “platform” from multiple revenue 
streams. Similarly, Case NMD identified several busi-
ness models that might be appropriate depending on 
the success of the technology and its clinical applica-
tion. However, such changes are not evident from the 
outset and do not appear to be readily designed, as they 
often emerge and evolve along with the innovation. 
Value network risk
The prevalent approach from the cases was to first 
build transient partnerships. In doing so, the case firms 
developed knowledge and built relationships over time, 
thereby reducing risks. More robust relationships and 
long-term alliances were developed later. There is a 
‘trading off’ of some short-term risk (by not having well-
established networks) against making a “bad decision” 
on a longer-term partner. The alternative – to delay the 
formation of any partnerships and thus delay the innov-
ation itself – was also observed in Case DH2, which ulti-
mately was a failed venture.
Internal organizational risks
The risk of an innovation not being accepted by the in-
cumbent organization is widely accepted in the literat-
ure (e.g., Danneels, 2011). To avoid resistance and 
mitigate organizational risk, the cases made multiple 
but small changes to existing routines. Examples of this 
approach were identified in Cases NMD, CMTI, and 
DH1.
Summarizing approaches for addressing complexity and 
integration
Risks arose from multiple sources: these risks could be 
considered in isolation, but they are interrelated. They 
form elements of a complex system, but rather than at-
tempting to simplify the system, it is suggested that the 
complexity is more often addressed in a holistic way. 
For example, Case MLD undertook multiple risk re-
views, whereby, they address patient and user risks, 
technology risk, business model risks, and overall pro-
ject management risks. Similarly, Case NMD took a sys-
temic approach to managing risks, and having mapped 
the major risk areas at an early stage, they set about ad-
dressing those risks in multiple areas (including for ex-
ample understanding the human biology, developing 
human-machine interfaces, developing new energy sys-
tems, and developing new ways to interpret novel data). 
The evidence suggests a move beyond the multiple risk 
approaches identified for disruptive innovation (e.g., 
Keizer & Halman, 2007) to more comprehensive models 
as proposed by O’Connor and Rice (2013). 
Despite knowing these represent categories of uncer-
tainty that need to be addressed, it does not answer the 
core question – how? Revisiting the case evidence indic-
ates several approaches being employed. Some are 
rooted in process, for example, in conducting formal risk 
assessments (as in Cases MLD and NMD) and making 
changes to processes to minimize or mitigate risk (as in 
cases NMD and DH1). Others aimed at building rela-
tions (evident in the Cases NMD, MLD, DH1, and CMTI, 
as previously discussed). Finally, there are cases that are 
more elusive and harder to classify, but are broadly 
based around management decisions and propensity to 
address wider ecosystem risks or in shaping the innova-
tion “agency”. 
An early treatise on innovation by Usher (1966), revised 
from a book originally written in 1926, identifies two 
types of action that innovators may use: analytic (ana-
lysis) and synthesis. Analytic approaches can be con-
ceived as using systematic methods to address largely 
anticipated or perceived gaps. Synthesis approaches are 
more creative and look to position the innovation to 
take advantage of future options. Revisiting the activity 
system suggested earlier (Figure 2), the underpinning 
routines may be conceived as being either largely ana-
lysis or largely synthesis driven by either a process, rela-
tional, or agency focus. This view suggests a conceptual 
model (Figure 3) that aims to position the integrating 
and risk management activities, in context, with the un-
derlying approach. 
This view also suggests approaches that are non-
deterministic. Equally, they are not arbitrary, but non-
ergodic (Sydow et al., 2012). In such a complex ecosys-
tem, it is unlikely that any previous state will be re-ex-
perienced and, hence, innovation approaches become 
more context sensitive. The challenge is in embracing 
Technology Innovation Management Review September 2017 (Volume 7, Issue 9)
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the complexity and managing the integration. Import-
antly, the innovator should not fixate too much on any 
one of the axes in Figure 3, but should look to “flex” 
between analytic and synthesis actions as needed and 
as opportunities arise. 
There appears from the cases to be no single way of or-
ganizing, but they suggest a combination of activities 
and capabilities to access information and partners, to 
respond to technological, organizational, and ecosys-
tem changes, and to maintain a focus on outcomes and 
performance. To quote one of the interviewees from 
Case DH2: “...convergence requires you to keep all those 
different parts synchronized. It’s no good progressing one 
too fast… from a whisky perspective, we have someone 
called ‘The Nose’. They are irreplaceable, they have an in-
stinctive nose, to make it all work. It’s not just science. 
But it’s not art either. Convergence is somewhere on that 
spectrum.”
Conclusion
The case evidence suggests innovators should under-
take multiple engagements with diverse stakeholders as 
part of a search, sense-making, and selection process. 
Critically, this process can also help to create credibility 
and visibility within the ecosystem – necessary precurs-
ors to form alliances and create opportunities to achieve 
first-mover advantage. Innovators also have an oppor-
tunity to shape outcomes and their value network, but 
the importance of supporting and sustaining the emer-
ging ecosystem is also identified here as a key activity. 
Activities to sustain and support an innovation (or to 
shape it) are largely a result of management agency – to 
identify opportunities or challenges and then act to ad-
dress them. The development of credibility, and later 
advantage-seeking positions, are the result of relational 
activities. The physical creation of value, integration, 
and the reduction of risk are primarily process driven. 
Actions to sustain, to seek credibility, and to reduce risk 
are effected by analytic approaches (analysis), in assess-
ing the current state, developing options, and then de-
ciding the best course. Finally, the value creation, 
advantage-seeking, and shaping activities are more 
about synthesis – identifying opportunities in patterns 
as they emerge. 
This exploratory research addresses a relatively new 
phenomenon and so is limited to a few cases, therefore, 
limiting the generalizability. A qualitative approach was 
used, but despite significant observations and inter-
views, risk remains in inference and interviewee reliab-
ility. Our cases are focused on the United Kingdom but 
also involve partners from outside the UK. Although the 
cases are longitudinal, they were only studied for two 
years; however, they represent a formative part of the 
specific innovations and include major decisions or 
pivot points. 
Future research would point to the need to better un-
derstand the emergence of such ecosystems and their 
impact on innovator processes in different contexts 
(e.g., different convergence regimes).
In summary, convergent innovation brings increased 
complexity and integration challenges that are not de-
terministic. There is a need to “embrace the complex-
ity” by adopting a variety of approaches that balance 
credibility-seeking and advantage-seeking behaviours 
Figure 3. Integration of innovation activities
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and oscillate between analysis and synthesis actions to 
address technological system, market, organizational, 
and value network integration risks. Although limited to 
a few cases in an emerging ecosystem, by taking a con-
temporaneous and longitudinal case approach, we ad-
dress an identified gap in the literature on “how” 
organizations innovate in this context. 
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